Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer.

Jiang, Huning; Cui, Jiahua; Chu, Hao; Xu, Tingting; Xie, Mengyan; Jing, Xinming; Xu, Jiali; Zhou, Jianwei; Shu, Yongqian

Jiang, Huning; Cui, Jiahua; Chu, Hao; Xu, Tingting; Xie, Mengyan; Jing, Xinming; Xu, Jiali; Zhou, Jianwei; Shu, Yongqian.

Afiliação

Jiang H; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Cui J; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Chu H; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xu T; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xie M; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Jing X; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Xu J; Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Zhou J; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Shu Y; Department of Molecular Cell Biology & Toxicology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.

Cell Death Discov ; 8(1): 235, 2022 Apr 29.

Article em En | MEDLINE | ID: mdl-35487914

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article